Thrombopoietin Receptor Agonists: Eltrombopag and Romiplostim for the Treatment of Chronic Immune Thrombocytopenia Purpura.

This article reviews ITP treatment for adult and pediatric patients, including the use of the oral agent eltrombopag and the injectible agent romiplostim, nursing considerations, and patient education.
PMID: 30880797 [PubMed - in process]

Source: Clinical Journal of Oncology Nursing - March 19, 2019 Category: Nursing Authors: Atkinson K Tags: Clin J Oncol Nurs Source Type: research